tiprankstipranks
Trending News
More News >
Biomea Fusion (BMEA)
NASDAQ:BMEA
US Market
Advertisement

Biomea Fusion (BMEA) Drug Pipeline

Compare
861 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Bmf-219
Type 1 Diabetes Mellitus
Phase II
Active Not Recruiting
Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus
Nov 10, 2023
Bmf-500
Acute Myeloid Leukemia
Phase I
Recruiting
A Phase 1, Study of BMF-500 in Adults With Acute Leukemia
May 18, 2023
Bmf-219
Colorectal Cancer, Pancreatic Cancer, Non Small Cell Lung Cancer, Nsclc, Stage Iv Pancreatic Cancer, Stage Iv Non-Small Cell Lung Cancer, Refractory Cancer, Pdac, Crc, Relapsed Cancer, Stage Iii Pancreatic Cancer, Stage Iii Non-Small Cell Lung Cancer, Stage Iii Colorectal Cancer, Stage Iv Colorectal Cancer, Stage Iii Nsclc, Stage Iv Nsclc, Kras Mutation-Related Tumors
Phase I
Terminated
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer
Nov 04, 2022
Bmf-219
Multiple Myeloma, Acute Myeloid Leukemia, Cancer, Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin, Small Lymphocytic Lymphoma, Diffuse Large B Cell Lymphoma, Lymphoma, Acute Lymphoblastic Leukemia, Plasma Cell Myeloma, Myeloma, Plasma-Cell, Myelomatosis, Acute Mixed-Phenotype Leukemia, Refractory, Progression
Phase I
Terminated
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
Nov 30, 2021
Bmf-219
Type 2 Diabetes Mellitus
Phase I/II
Completed

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Biomea Fusion (BMEA) have in its pipeline
      BMEA is currently developing the following drugs: Bmf-219, Bmf-500, Bmf-219. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis